IPF TODAY
BREATHE, DREAM & LIVE
IPF Today
Vienna, VA
United States
info
IPF news 2011 - 2018
In the past twenty years, news on IPF was rare but in the last few years a flurry of articles has hit the news. Promising research, publications about Esbriet and Ofev, clinical trials and opinions of specialists have come out almost weekly. Reading all the articles provides confidence that the medical sector and pharmaceutical companies are closing in on more and better solutions.
We don't feel that we have to reproduce the idiopathic pulmonary fibrosis news here. That's why this page will be depending on our daily online research plus contributions of readers and will consist of the links to the news/info. If you find important information, a good article or even a hopeful sign, please let us know and we'll put the link up asap. Articles will be given the date (marked in red) we found them on the web. Just click or even copy and paste in your address bar.
**Please understand that some articles are very technical but we have those in our list because doctors, researchers and other professions may read them.
December 19 2018 - Lung transplant patients face elevated lung cancer risk
https://www.eurekalert.org/pub_releases/2018-12/w-ltp121718.php
December 19 2018 - Bridge Biotherapeutics announces FDA Clearance for idiopathic pulmonary fibrosis treatment
http://www.koreabiomed.com/news/articleView.html?idxno=4781
December 18 2018 - Researchers make important breakthrough in pulmonary fibrosis
https://medicalxpress.com/news/2018-12-important-breakthrough-pulmonary-fibrosis.html
December 17 2018 - Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
December 17 2018 - Galapagos NV (GLPG) Reports First Patient Dosing in ISABELA Phase 3 Program with GLPG1690 in Patients with Idiopathic Pulmonary Fibrosis
December 13 2018 - ATS Panel: U.S. Home Oxygen Delivery System Broken
https://www.medpagetoday.com/pulmonology/smokingcopd/76892
December 10 2018 - A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology
December 06 2018 - Veracyte Expands Early Access for Genomic Lung Disease Classifier
December 05 2018 - Five year lung plan calls for wider use of spirometry
https://www.bmj.com/content/363/bmj.k5148
December 03 2018 - Ninjurin1 Plays a Crucial Role in Pulmonary Fibrosis by Promoting Interaction between Macrophages and Alveolar Epithelial Cells
https://www.nature.com/articles/s41598-018-35997-x
December 03 2018 - Nuformix Reports Results from Novel Pre-Clinical Trial in IPF for NXP002 Programme
https://nuformix.com/app/uploads/2018/12/NFX-NXP002-IPF-Results-RNS-FINAL.pdf
November 26 2018 - Middle-aged adults with lung disease may have greater risk of dementia later in life
November 20 2018 - Pliant Therapeutics receives orphan drug designation for PSC, IPF drug
November 07 2018 - A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway
https://www.nature.com/articles/s41598-018-35320-8
November 14 2018 - Redx Pharma Nominates First Development Compound To Treat Fibrosis
November 07 2018 - Solid Phase II Performance for French Autoimmune Liver Disease Drug
https://labiotech.eu/medical/genkyotex-autoimmune-liver-disease-phase-ii/
October 26 2018 - East River BioSolutions Awarded NIH SBIR Phase I Grant
https://xylyxbio.com/nihsbirphaseigrant/
October 26 2018 - Danish Biotech Closes €79M Series C to Develop Inhaled Lung Disease Drug
https://labiotech.eu/medical/galecto-funding-lung-disease/
October 25 2018 - MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
https://www.nejm.org/doi/full/10.1056/NEJMoa1801562
October 24 2018 - Mucus, cough and chronic lung disease: New discoveries
https://www.eurekalert.org/pub_releases/2018-10/uog-mca102418.php
October 24 2018 - Tejaswini Kulkarni, MD, MPH: Defining & Diagnosing Acute Exacerbations of IPF
October 22 2018 - United Therapeutics to Develop CollPlant Technologies for 3D Bioprinted Lung Transplants
October 22 2018 - CU researchers find common genetic link in lung ailments
https://www.eurekalert.org/pub_releases/2018-10/uoca-crf102218.php
October 19 2018 - Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194203/
October 15 2018 - IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196226/
October 11 2018 - Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound
October 10 2018 - The effects of cabin pressurisation on patients with respiratory conditions
October 10 2018 - As Partner In The INAT Consortium Secarna Pharmaceuticals Receives Horizon 2020 Grant To Develop Inhaled Nanocarriers With Antisense Therapy As A Novel Therapeutic Approach For Lung Fibrosis
http://www.digitaljournal.com/pr/3973140
October 102018 - S&R Foundation Presents 2018 Kuno Award for Applied Science to Dr. Mary Armanios, Johns Hopkins University
October 10 2018 - Thousands Of Americans Have Pulmonary Fibrosis, Many Not Diagnosed
October 08 2018 - Veracyte Announces Presentation of Data Confirming Envisia Genomic Classifier’s Ability to Improve Diagnosis of Idiopathic Pulmonary Fibrosis
October 08 2018 - X-Rx Announces Completion of IND-enabling Studies with X-165 for the Treatment of Idiopathic Pulmonary Fibrosis and other Fibrotic Indications
October 07 2018 - Hospitalized ILD Patients Fare Much Worse from Gram-Negative Bacteria
October 04 2018 - Study reveals new targets to inhibit pulmonary fibrosis
http://news.vumc.org/2018/10/04/study-reveals-new-targets-to-inhibit-pulmonary-fibrosis/
October 03 2018 - Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0899-4
October 03 2018 - How does rheumatoid arthritis affect the lungs?
https://www.medicalnewstoday.com/articles/323248.php
October 02 2018 - BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo
https://www.spandidos-publications.com/10.3892/ijmm.2018.3914
September 27 2018 - Exercise Training for Interstitial Lung Disease
https://www.physiciansweekly.com/exercise-training-for-interstitial-lung-disease/
September 26 2018 - Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
https://stemcellres.biomedcentral.com/articles/10.1186/s13287-018-0970-6
September 26 2018 - PD-1+ T cells trigger pulmonary fibrosis
September 26 2018 - Genkyotex Exceeds Patient Enrollment Target in its Phase 2 Trial with GKT831 for Primary Biliary Cholangitis
September 21 2018 - PROOF Registry Study Reaffirms Benefit of Using Pirfenidone to Treat IPF
September 20 2018 - Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study
https://www.apnews.com/59a4aa14466ecdbd84c6a1b6b935681f
September 20 2018 - Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
September 19 2018 - No Benefit From Nintedanib Plus Sildenafil in Idiopathic Pulmonary Fibrosis
September 17 2018 - United Therapeutics Acquires North American Rights to Samumed IPF Candidate SM04646
September 15 2018 - Deep learning and the evaluation of pulmonary fibrosis
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30371-0/fulltext
September 14 2018 - Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30339-4/fulltext
September 12 2018 - Fast Track Designation Granted to Idiopathic Pulmonary Fibrosis Treatment, Pamrevlumab
September 11 2018 - Lung Organoids: Methodology, Research and Applications
September 11 2018 - Cedars-Sinai receives $12 million from NIH to investigate deadly lung conditions
September 11 2018 - Interstitial Lung Disease Diagnosis Improved Using Rheumatologic Assessment
September 07 2018 - Coalition wants liquid oxygen out of bid program
http://www.hmenews.com/article/coalition-wants-liquid-oxygen-out-bid-program
September 06 2018 - Bristol-Myers Squibb And NASH: Where Do We Stand?
https://seekingalpha.com/article/4204468-bristol-myers-squibb-nash-stand
September 06 2018 - UA researchers receive $4.4 million grant to focus on idiopathic pulmonary fibrosis
September 04 2018 - Roivant Adds Investigational Therapeutic for the Treatment of Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis to Pipeline
September 03 2018 - New pulmonary fibrosis videos raise awareness
https://www.capegazette.com/article/new-pulmonary-fibrosis-videos-raise-awareness/164692
September 03 2018 - Qure.AI: This startup’s AI products make MRI, CT scans or X-rays easy to diagnose
August 31 2018 - Sequential changes of serum KL-6 predict the progression of interstitial lung disease
August 31 2018 - New guideline aids in diagnosing idiopathic pulmonary fibrosis
https://www.eurekalert.org/pub_releases/2018-08/ats-nga082918.php
August 29 2018 - Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30289-3/fulltext
August 28 2018 - Lung Tissue Chip Offers Rapid Testing of Anti-Fibrotic Drugs
https://www.newswise.com//articles/lung-tissue-chip-offers-rapid-testing-of-anti-fibrotic-drugs
August 23 2018 - Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis
https://www.nature.com/articles/s41598-018-31214-x
August 23 2018 - UAB Receives $8.9 Million Grant to Continue Testing of New Drug for IPF
August 23 2018 - Bridge Bio to submit IND application for idiopathic pulmonary fibrosis treatment
http://www.theinvestor.co.kr/view.php?ud=20180823000511
August 21 2018 - Genkyotex cashes in €7.5m
https://european-biotechnology.com/up-to-date/latest-news/news/genkyotex-cashes-in-eur75m.html
August 17 2018 - Anti-Reflux Surgery Slows Idiopathic Lung Fibrosis
https://www.medpagetoday.org/pulmonology/generalpulmonary/74617?vpass=1
August 17 2018 - AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1007562
August 15 2018 - First Mouse Model to Mimic Lung Disease Could Speed Discovery of More Effective Treatments
August 14 2018 - Orphan Drug Designation Granted to Bronchiolitis Obliterans Treatment, OSP-101
August 14 2018 - Prometic fibrosis candidate reduces hepatic stellate cell activation
August 14 2018 - Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: A retrospective study
August 10 2018 - Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo
https://www.atsjournals.org/doi/abs/10.1165/rcmb.2017-0289OC
August 10 2018 - Research Discovers Mechanism of Fibrosis Development
August 9 2018 - Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30301-1/fulltext
August 8 2018 - Serum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis
http://jtd.amegroups.com/article/view/23805/18334
August 6 2018 - Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
August 3 2018 - Scientists Discover New Type of Lung Cell
http://www.sci-news.com/biology/new-type-lung-cell-pulmonary-ionocyte-06271.html
August 3 2018 - Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis
https://www.atsjournals.org/doi/abs/10.1164/rccm.201708-1580OC?journalCode=ajrccm
August 3 2018 - Engineered pig lung transplant 'a success'
https://www.bbc.com/news/science-environment-45046674
August 2 2018 - US NIH awards grant for Phase ll trial of GKT831 to treat IPF
https://www.drugdevelopment-technology.com/news/nih-awards-grant-phase-ll-trial-gkt831-treat-ipf/
July 31 2018 - Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis
July 31 2018 - Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: A candidate gene sequencing study
July 28 2018 - The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0845-5#Sec5
July 26 2018 - aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference
July 26 2018 - Researchers design a nano-carrier to release drugs into damaged cells
https://www.eurekalert.org/pub_releases/2018-07/ifri-rda072618.php
July 25 2018 - Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201154#sec010
July 25 2018 - How Can I Find the Best Pulmonologist?
https://health.usnews.com/health-care/patient-advice/articles/how-can-i-find-the-best-pulmonologist
July 24 2018 - Lung Transplant Survival Lower During Acute Exacerbations of IPF
July 24 2018 - OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing
July 24 2018 - Lung Plethysmography Procedure
https://www.news-medical.net/health/Lung-Plethysmography-Procedure.aspx
July 24 2018 - HU professor nabs $1.3 million grant to study lung disease
http://www.dailypress.com/news/education/dp-nws-education-notebook-0724-story.html
July 20 2018 - UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments
July 20 2018 - First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis
https://clinicaltrials.gov/ct2/show/NCT03559166
July 19 2018 - Pulmonary Fibrosis Foundation Launches New PF Health App
July 12 2018 - Why internal scars won't stop growing
https://www.sciencedaily.com/releases/2018/07/180712100527.htm
July 16 2018 - Priyanka Chopra to star in Shonali Bose film
July 16 2018 - Dubai: Region’s first ‘fit-to-fly" medical test launched
https://gulfnews.com/news/uae/society/region-s-first-fit-to-fly-medical-test-launched-1.2248749
July 11 2018 - High prevalence of restrictive lung disease in people with type 2 diabetes
https://www.eurekalert.org/pub_releases/2018-07/dzfd-hpo071118.php
July 10 2018 - NuMedii Inks Single-Cell Sequencing Collaborations With Yale, Brigham and Women's Hospital
July 9 2018 - A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038197/
July 9 2018 - Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
July 2 2018 - Metformin reverses established lung fibrosis in a bleomycin model
https://www.nature.com/articles/s41591-018-0087-6#additional-information
June 27 2018 - Galectin Therapeutics Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis
June 27 2018 - Pulmonary Fibrosis Foundation Launches Oxygen Information Line
June 25 2018 - The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026799/
June 22 2018 - A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0810-3
June 21 2018 - The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies
http://erj.ersjournals.com/content/51/6/1800376
June 21 2018 - Interstitial Lung Disease May Trigger Microscopic Polyangiitis in Some Patients, Case Report Suggests
June 19 2018 - Low vitamin D linked to scarring lung disease
June 18 2018 - Paragonix Technologies, Inc. Announces Partnership with the Lung Transplant Foundation to Support Commercialization of Paragonix SherpaLung™ for Improved Donor Lung Transport
June 13 2018 - 10 patients safely receive hepatitis C-infected lungs in new clinical trial
June 12 2018 - A Chronic, Rare Lung Disease Causes More Than Just Irreversible Scarring Of The Lungs
June 12 2018 - Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0806-z
June 7 2018 - Recombinant human pentraxin 2 slows the decline in lung function for patients with idiopathic pulmonary fibrosis
June 5 2018 - ZappRx Expanding Partnership with PARx Solutions as Part of Their Growth into New Treatment Areas
June 4 2018 - France Foundation-Genentech Initiative to Improve IPF Diagnosis, Treatment at Local Level
May 31 2018 - Respiratory rate 2: anatomy and physiology of breathing
May 30 2018 - Florida Orlando Hospital Has Particularly Low Mortality, Length of Stay, & Readmission Rates for Interstitial Lung Disease With Major Complications
https://dexur.com/a/ild-ipf-florida-orlando-duke-university-johns-hopkins-cleveland-clinic/397/
May 29 2018 - Antifibrotic Drug Stabilized Lung Function For Patients with Idiopathic Pulmonary Fibrosis
May 25 2018 - Lung-on-a-chip simulates pulmonary fibrosis
http://www.buffalo.edu/news/releases/2018/05/038.html
May 25 2018 - Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197936
May 23 2018 - Pulmonologists Favor Antifibrotic Treatment Immediately After IPF Diagnosis
May 22 2018 - Pliant Therapeutics Presents Idiopathic Pulmonary Fibrosis Biomarker Discovery Research at American Thoracic Society 2018 International Conference
https://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=278316
May 22 2018 - Prometic presents new clinical data on PBI-4050 for the treatment of idiopathic pulmonary fibrosis
May 21 2018 - FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018
May 21 2018 - Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-018-0644-2
May 21 2018 - A4275 / 224 - Physician Characteristics Associated with Treatment Initiation Patterns in Idiopathic Pulmonary Fibrosis: Results from an Online, Self-Administered Survey
http://www.abstractsonline.com/pp8/#!/4499/presentation/15317
May 20 2018 - Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(18)30181-4/fulltext
May 20 2018 - Test therapy shows promise against chronic lung disease
https://newsroom.uw.edu/postscript/new-drug-treatment-shows-promise-slowing-chronic-lung-disease
May 17 2018 - Hypersensitivity Pneumonitis and Acute Respiratory Distress Syndrome From E-Cigarette Use
http://pediatrics.aappublications.org/content/early/2018/05/15/peds.2016-3927
May 17 2018 - Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test
May 15 2018 - Pulmonary Fibrosis Foundation Extends Care For Patients With Deadly Lung Disease
May 14 2018 - Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus
https://www.nature.com/articles/s41557-018-0039-2
May 11 2018 - Samumed Announces Presentation at the 2018 American Thoracic Society (ATS) International Conference
May 10 2018 - FDA Continues Crack Down on Unapproved Stem Cell Clinics
https://www.medscape.com/viewarticle/896499
May 9 2018 - Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938700/
May 9 2018 - AdAlta CEO Sam Cobb Discusses IPF Therapy Development
https://www.raredr.com/news/adalta-ceo-sam-cobb
May 7 2018 - Blocking the Molecular Source of Idiopathic Pulmonary Fibrosis
https://labblog.uofmhealth.org/lab-report/blocking-molecular-source-of-idiopathic-pulmonary-fibrosis
May 4 2018 - Mobilizing the University to Fight a Common Killer - UVA
https://engineering.virginia.edu/news/2018/05/mobilizing-university-fight-common-killer
April 30 2018 - Avoiding Drug–Drug Interactions in Patients With Respiratory Diseases
April 27 2018 - Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-018-0626-4
April 26 2018 - Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: A case report
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010629/
April 24 2018 - Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0783-2
April 23 2018 - Pulmonary rehabilitation can ease lung issues like COPD, cystic fibrosis
http://www.nwherald.com/sponsored/articles/2018/04/23/00915356/index.xml
April 23 2018 - Banned enhancement drug removed from UAE shelves
https://gulfnews.com/news/uae/health/banned-enhancement-drug-removed-from-uae-shelves-1.2210070
April 19 2018 - Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation
https://www.nature.com/articles/s41598-018-24565-y
April 18 2018 - AdAlta to advance improved lung fibrosis therapy, AD-214
http://adalta.com.au/adalta-advance-improved-lung-fibrosis-therapy-ad-214/
April 18 2018 - ALA Offers New Resources to IPF Patients
https://www.raredr.com/sap-partner/ala/ala-new-resources-ipf
April 18 2018 - NuvoAir Launches Air Next, Revolutionary New Home Device to Help Those With Serious Lung Conditions
April 16 2018 - IPF Outcomes Improved by Reflx treatment
April 13 2018 - Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences
April 13 2018 - Bristol-Myers Collaborates With Harvard Fibrosis Network
https://www.zacks.com/stock/news/299195/bristolmyers-collaborates-with-harvard-fibrosis-network
April 12 2018 - BRIEF-Galapagos Announces Isabela Phase 3 Program In IPF
April 11 2018 - Kadmon gets FDA go-ahead for ROCK2 inhibitor study
https://www.biopharmadive.com/news/kadmon-gets-fda-go-ahead-for-rock2-inhibitor-study/521086/
April 10 2018 - Scientists find new molecular target to treat idiopathic pulmonary fibrosis
April 10 2018 - Reviva Pharmaceuticals Receives FDA Orphan Designation for RP5063 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
April 3 2018 - Pop-up institutes help medical research advance quickly, cheaply
April 3 2018 - Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-018-0204-7
April 1 2018 - A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis
https://ajp.amjpathol.org/article/S0002-9440(17)30901-X/fulltext
March 29 2018 - Effect of Antifibrotics on Short-Term Outcome after Bilateral Lung Transplantation A Multi-Centre Analysis
http://erj.ersjournals.com/content/early/2018/03/29/13993003.00503-2018
March 27 2018 - PMD Healthcare Releases Top-Line Findings of 2018 Cystic Fibrosis and Pulmonary Fibrosis Patient Online Research Surveys
March 22 2018 - A Brief Look at the Clinical Uses of N-Acetylcysteine
March 22 2018 - Reata links bardoxolone to improved walk test results in interstitial lung disease patients
March 22 2018 - https://www.dovepress.com/the-reliability-of-lung-ultrasound-in-assessment-of-idiopathic-pulmona-peer-reviewed-article-CIA
March 13 2018 - HGE Health Extends Its Telemedicine Technology Successes From One Disease To Another
March 8 2018 - CDC Finds Cluster of Pulmonary Disease in Dentists
https://www.medscape.com/viewarticle/893657
March 52018 - Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4
https://www.nature.com/articles/s41598-018-21889-7
March 5 2018 - Restoring lipid synthesis could reduce lung fibrosis
https://www.sciencedaily.com/releases/2018/03/180305165842.htm
March 2 2018 - American Journal of Pathology Publishes Data from Study of PBI-4050 in IPF
http://www.raredr.com/news/pbi4050-ipf-data
February 28 2018 - Boehringer Ingelheim Starts New Campaign: ‘Why wait in IPF?’
February 26 2018 - New Data Suggests I-Body Technology Could Treat Lung Fibrosis
http://www.raredr.com/news/ibody-technology-ipf
February 23 2018 - ASU scientists unveil a hidden secret of the immortality enzyme telomerase
https://asunow.asu.edu/20180223-discoveries-asu-scientists-unveil-immortality-enzyme-telomerase
February 23 2018 - Two in one: human placenta stem cells hold a dual benefit
https://www.uq.edu.au/news/article/2018/02/two-one-human-placenta-stem-cells-hold-dual-benefit
February 23 2018 - Azithromycin: A New Treatment Hope for Idiopathic Pulmonary Fibrosis?
https://www.medscape.com/viewarticle/892350
February 16 2018 - A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
http://ajp.amjpathol.org/article/S0002-9440(17)30804-0/fulltext
February 15 2018 - PMD Healthcare Announces Two New Patient Advisory Boards
February 13 2018 - MediciNova raises $40 million in stock offering
http://www.sandiegouniontribune.com/business/biotech/sd-me-medicinova-offering-20180213-story.html
February 12 2018 - Kadmon Announces Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary Fibrosis
February 7 2018 - Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis
https://www.karger.com/Article/Abstract/486286
February 6 2018 - NICE restricts NHS use of Roche’s IPF drug Esbriet
http://www.pharmatimes.com/news/nice_restricts_nhs_use_of_roches_ipf_drug_esbriet_1220581
February 1 2018 - Study tracks therapy to slow idiopathic pulmonary fibrosis
https://news.vanderbilt.edu/2018/02/01/study-tracks-therapy-to-slow-idiopathic-pulmonary-fibrosis/
January 29 2018 - Prometic's PBI-4050: Phase 3 Pivotal Clinical Trial Design for Idiopathic Pulmonary Fibrosis (IPF) Finalized
January 26 2018 - Owlstone Medical’s Breath Biopsy Wins Global IPF Catalyst Challenge
January 18 2018 - Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease
http://www.digitaljournal.com/pr/3626972
January 15 2018 - Inhalation technology: the future of effective respiratory treatments
January 12 2018 - Low Activity of Transcription Factor Triggers Pulmonary Fibrosis
https://www.coherentnews.com/low-activity-of-transcription-factor-triggers-pulmonary-fibrosis/
January 10 2018 - Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-018-0714-2
January 10 2018 - Seven IPF Experts Named to NuMedii Advisory Board
http://www.raredr.com/news/numedii-advisory-board-ipf
January 8 2018 - Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA
https://labiotech.eu/galapagos-proqr-fibrosis-rna/
January 3 2018 - Bellerophon Announces First Patient Enrolled in Phase 2b Study Evaluating INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
January 1 2018 - A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis
https://www.atsjournals.org/doi/10.1164/rccm.201704-0784OC
December 28 2017 - mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
http://openres.ersjournals.com/content/3/4/00084-2017
December 27 2017 - Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice.
https://www.ncbi.nlm.nih.gov/pubmed/29262578
December 21 2017 - Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung
https://insight.jci.org/articles/view/96352
December 18 2017 - Prometic's Plasminogen (Ryplazim™) granted orphan drug designation for the treatment of idiopathic pulmonary fibrosis (IPF)
December 13 2017 - Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis—an interim analysis of results from a prospective, single-center, randomized, parallel-group study
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0523-2
December 11 2017 - Prometic's PBI-4050 Receives Promising Innovative Medicine (PIM) Designation From The UK MHRA In The Treatment Of Idiopathic Pulmonary Fibrosis
December 8 2017 - Stem Cells Help Repair Injured Lungs Read more from Asian Scientist
https://www.asianscientist.com/2017/12/in-the-lab/lung-stem-cells-repair/
December 7 2017 - FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
http://embomolmed.embopress.org/content/early/2017/12/07/emmm.201606261
December 6 2017 - Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0513-4
December 5 2017 - Thyroid hormone therapy heals lung fibrosis in animal study
https://news.yale.edu/2017/12/04/thyroid-hormone-therapy-heals-lung-fibrosis-animal-study
December 4 2017 - Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration
https://www.nature.com/articles/s41598-017-17007-8
November 28 2017 - Endogenous protein reverses scarring in the lungs
https://phys.org/news/2017-11-endogenous-protein-reverses-scarring-lungs.html
November 27 2017 - aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)
November 21 2017 - Nuclear hyaluronidase 2 drives alternative splicing of CD44 pre-mRNA to determine profibrotic or antifibrotic cell phenotype
http://stke.sciencemag.org/content/10/506/eaao1822.long
November 20 2017 - Cipla gets USFDA approval for anti-asthma product
https://www.biospectrumindia.com/news/73/9851/cipla-gets-usfda-approval-for-anti-asthma-product.html
November 20 2017 - Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition
https://www.nature.com/articles/s41598-017-14602-7
November 17 2017 - Analytical performance of Envisia: a genomic classifier for usual interstitial pneumonia
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0485-4
November 15 2017 - Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions
https://medicalxpress.com/news/2017-11-molecular-pathway-treatment-pulmonary-fibrosis.html
November 14 2017 - Merck (MRK) Gets CHMP Nod for Infection Candidate Prevymis
https://www.nasdaq.com/article/merck-mrk-gets-chmp-nod-for-infection-candidate-prevymis-cm877057
November 14 2017 - Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF‑β1, TNF‑α and NF‑κB
https://www.spandidos-publications.com/10.3892/mmr.2017.8056/abstract
November 14 2017 - Grupo Biotoscana buys Argentina-based specialty pharma manufacturer Laboratorio DOSA
http://www.pharmabiz.com/NewsDetails.aspx?aid=105454&sid=2
November 10 2017 - Results from six-month lung imaging study showed slowing of fibrotic progression in patients with IPF treated with Ofev® versus placebo
November 8 2017 - Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
https://www.nature.com/articles/s41598-017-15198-8
November 8 2017 - Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study
https://www.sciencedirect.com/science/article/pii/S1094553917300603?via%3Dihub
November 4 2017 - Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
http://erj.ersjournals.com/content/50/4/1701157?ctkey=shareline
November 3 2017 - Esbriet for IPF: Reconsidering Its Role
http://www.mdmag.com/conference-coverage/chest-2017/esbriet-for-ipf-reconsidering-its-role
November 3 2017 - Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis
November 2 2017 - Sanofi ditches IL-4/IL-13 antibody drug in lung-scarring disease
https://www.fiercebiotech.com/biotech/sanofi-ditches-il4-il13-antibody-drug-lung-scarring-disease
October 27 2017 - Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis
https://www.nature.com/articles/s41598-017-14612-5
October 25 2017 - Prometic Receives Fast Track Designation for PBI-4050 in Development for Idiopathic Pulmonary Fibrosis (IPF)
October 23 2017 - ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
https://www.nature.com/articles/nm.4419
October 20 2017 - Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(17)30387-9/fulltext
October 20 2017 - Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186615
October 16 2017 - Timing of onset of symptoms in people with idiopathic pulmonary fibrosis
http://thorax.bmj.com/content/early/2017/10/11/thoraxjnl-2017-210177.full
October 12 2017 - British Researchers Connect IPF to Mesothelioma and Asbestosis
https://mesothelioma.net/mesothelioma-news/british-researchers-connect-ipf-mesothelioma-asbestosis/
October 11 2017 - Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis
October 10 2017 - Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0476-5
October 9 2017 - OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
October 3 2017 - Anxiety and Depression Affect Quality of Life in Idiopathic Pulmonary Fibrosis
October 2 2017 - R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185811#sec025
September 25 2017 - BRIEF-Prometic receives FDA clearance of its IND to initiate PBI-4050 phase 2/3 trial in patients with idiopathic pulmonary fibrosis
September 22 2017 - Patara Pharma's Phase 2 Study Results for Treatment of Persistent Cough in IPF Patients Published in The Lancet Respiratory Medicine
September 22 2017 - Esbriet Seen to Offer Significant Benefits to IPF Patients in Pooled Analysis of Phase 3 Trials
September 21 2017 - Guidelines needed for 6MWT in idiopathic pulmonary fibrosis
https://medicalxpress.com/news/2017-10-guidelines-6mwt-idiopathic-pulmonary-fibrosis.html
September 11 2017 - Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184300
September 15 2017 - Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0468-5
September 11 2017 - Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-Renewal and Myofibrogenesis in the Lung
http://www.cell.com/cell/fulltext/S0092-8674(17)30870-X
September 11 2017 - miRagen Therapeutics Presents New MRG-201 Preclinical Data for Inhaled MicroRNA-29 Mimic Targeting Pulmonary Fibrosis
September 11 2017 - Safety and efficacy results from the INJOURNEYTM trial investigating OFEV® (nintedanib) with add-on pirfenidone provide new data to support nintedanib’s key role in IPF
September 7 2017 - Molecular Paths of Lung-Cell Development Could Provide Drug Targets for Disorders Like Pulmonary Fibrosis
September 6 2017 - Synairgen reports strong interest in new fibrosis treatment ahead of Phase I trial
September 5 2017 - Inventiva Announces Exercise of Option by Boehringer Ingelheim to Jointly Develop Potential New Treatments for Idiopathic Pulmonary Fibrosis (IPF)
September 5 2017 - Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
https://www.jci.org/articles/view/94624
September 1 2017 - Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563167/
August 24 2017 - TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647702/
August 21 2017 - Compelling new lung disease treatment pioneered in Victoria gains global attention alongside top researchers and drug developers
August 21 2017 - AstraZeneca, Ethris Collaborate to Develop mRNA-Based Respiratory Disease Therapies
August 18 2017 - Team of top researchers to tackle incurable lung diseases at University of Leicester
https://www.leicestermercury.co.uk/news/leicester-news/team-top-researchers-tackle-incurable-342741
August 11 2017 - Workplace fumes linked to signs of early lung disease
http://www.businessinsider.com/r-workplace-fumes-linked-to-signs-of-early-lung-disease-2017-8
August 9 2017 - New Mayo Clinic facility aims to increase lungs available for transplant
August 9 2017 - GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial
August 8 2017 - FibroGen shares rocket up on positive PhII data in idiopathic pulmonary fibrosis
https://endpts.com/fibrogen-shares-rocket-up-on-positive-phii-data-in-idiopathic-pulmonary-fibrosis/
August 7 2017 - Three Lakes Partners Now Accepting Submissions for $1,000,000 IPF Catalyst Challenge
August 4 2017 - Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
http://www.jimmunol.org/content/early/2017/07/28/jimmunol.1700473
August 4 2017 - Cellular aging process can promote idiopathic pulmonary fibrosis
August 3 2017 - Help for Lung Fibrosis Diseases?
https://www.newsmax.com/Health/Health-News/lung-fibrosis-diseases-stem/2017/08/03/id/805573/
August 3 2017 - Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse® in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
August 2 2017 - Antiinflammation and Antioxidant Effects of Thalidomide on Pulmonary Fibrosis in Mice and Human Lung Fibroblasts.
https://www.ncbi.nlm.nih.gov/pubmed/28730510
August 1 2017 - Aeolus Pharmaceuticals starts Phase 1 test of radiation exposure treatment
July 25 2017 - Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0444-0
July 24 2017 - People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey
July 24 2017 - SAMUMED receives orphan drug designation from FDA for SM04646 as a treatment for Idiopathic Pulmonary Fibrosis (IPF)
July 17 2017 - FibroGen: Update To Thesis - IPF Data In Focus
https://seekingalpha.com/article/4088129-fibrogen-update-thesis-ipf-data-focus
July 17 2017 - Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
http://onlinelibrary.wiley.com/doi/10.1002/psp4.12227/epdf
July 11 2017 - Scientists discover treatment target for pulmonary fibrosis https://medicalxpress.com/news/2017-07-scientists-treatment-pulmonary-fibrosis.html
July 7 2017 - MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
http://www.jbc.org/content/292/40/16420.short?rss=1
July 5 2017 - Keck School of Medicine of USC Receives $6.9 Million NIH Grant to Promote Ambitious Pulmonary Medicine Research
July 2 2017 - Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
https://www.medscape.com/viewarticle/881474
June 30 2017 - What Can We Expect from United Therapeutics’ Tyvaso in 2017?
https://marketrealist.com/2017/06/what-can-we-expect-from-united-therapeutics-tyvaso-in-2017
June 27 2017 - Tips on Obtaining Liquid Oxygen
June 22 2017 - Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning
https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201612-947OC
June 22 2017 - Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-017-0605-y
June 21 2017 - $10 million DNA sequencing effort aims to shed light on lung diseases
https://medicine.wustl.edu/news/10-million-dna-sequencing-effort-aims-shed-light-lung-diseases/
June 19 2017 - All-in-One Device Increases Bedside Spirometry Testing
June 15 2017 - Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
https://www.ncbi.nlm.nih.gov/pubmed/28232409
June 13 2017 - Idiopathic Pulmonary Fibrosis Algorithm Performs Poorly
https://www.doctorslounge.com/index.php/news/pb/72977
June 10 2017 - Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis
https://www.ncbi.nlm.nih.gov/pubmed/28258461
June 06 2017 - Lung Therapeutics, Inc. Raises $14.3 Million Series B Financing to Treat Unmet Needs in Lung Disease and Fibrosis
June 2 2017 - Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457546/
May 30 2017 - USC research could lead to treatment for common lung diseases
http://news.usc.edu/120670/usc-research-could-lead-to-treatment-for-common-lung-diseases/
May 26 2017 - Role of Stem Cells in Chronic Lung Diseases Revealed
May 23 2017 - Differences in Patient and Physician Viewpoints of the Management of Idiopathic Pulmonary Fibrosis (IPF)
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A1123
May 23 2017 - Effect of Pirfenidone on Breathlessness as Measured by the UCSD-SOBQ Score in Patients with Idiopathic Pulmonary Fibrosis (IPF) with Moderate Lung Function Impairment
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A5406
May 23 2017 - Improvement in Forced Vital Capacity (FVC) with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from The INPULSIS Trials
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A5399
May 23 2017 - Prometic Presents New Data on PBI-4050 and Plasminogen at the American Thoracic Society's 2017 International Conference
May 22 2017 - Positive Clinical Data on INOpulse® Presented at the American Thoracic Society 113th International Conference
http://investors.bellerophon.com/phoenix.zhtml?c=253899&p=irol-newsArticle&ID=2275682
May 19 2017 - The Resokine Pathway Is Implicated in the Pathology of Interstitial Lung Disease
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A7068
May 17 2017 - Drug to tackle lung scarring shows promise
http://www.ed.ac.uk/news/2017/drug-to-tackle-lung-scarring-shows-promise
May 15 2017 - Aeolus Announces Second Quarter Financial Results for Fiscal Year 2017
http://news.sys-con.com/node/4081546
May 15 2017 - Genoa Pharmaceuticals, led by biotech veteran Bruce Montgomery, raises $62M to fund clinical trials
May 13 2017 - 3D human lung model to shed light on respiratory diseases
May 10 2017 - Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017
May 9 2017 - FibroGen's (FGEN) CEO Tom Neff on Q1 2017 2016 Results - Earnings Call Transcript
May 4 2017 - Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
https://www.ncbi.nlm.nih.gov/pubmed/28471697
May 4 2017 - Proterris and Alfama Complete Merger to Create Global Leader in Carbon Monoxide Therapies for Acute and Chronic Diseases
May 3 2017 - Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413938/
May 2 2017 - New study makes strides towards generating lung tissue
https://medicalxpress.com/news/2017-05-lung-tissue.html
May 1 2017 - Unraveling the Mode of Action of Pulsed Inhaled NO in Severe IPF Using Functional Respiratory Imaging
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A1560
April 20 2017 - miRagen Therapeutics to Present MRG-201 Data at the Society for Investigative Dermatology Annual Meeting
https://clinicaltrials.gov/ct2/show/NCT02603224?term=MRG-201&rank=1
April 20 2017 - Cannabinoid CB1 receptor over-activity contributes to the pathogenesis of idiopathic pulmonary fibrosis
https://insight.jci.org/articles/view/92281
April 19 2017 - Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases
April 18 2017 - FDA confirms Prometic's PBI-4050 IPF clinical trial design
https://finance.yahoo.com/news/fda-confirms-prometics-pbi-4050-110000091.html
April 17 2017 - Fibrosis reversed when 'don't eat me' signal blocked, Stanford study finds
https://www.eurekalert.org/pub_releases/2017-04/sumc-frw041217.php
April 17 2017 - Bristol-Myers Squibb and Nordic Bioscience Announce Collaboration for Fibrosis Biomarker Technology
https://finance.yahoo.com/news/bristol-myers-squibb-nordic-bioscience-105900454.html
April 12 2017 - Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
https://www.ncbi.nlm.nih.gov/pubmed/28399537
April 11 2017 - NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis
April 5 2017 - Collagen-targeting PET probe may improve diagnosis and treatment of pulmonary fibrosis
https://medicalxpress.com/news/2017-04-collagen-targeting-pet-probe-diagnosis-treatment.html
March 31 2017 - Antibody is effective against radiation-induced pulmonary fibrosis
https://medicalxpress.com/news/2017-03-antibody-effective-radiation-induced-pulmonary-fibrosis.html
March 28 2017 - Kadmon (KDMN) Presents Preclinical Data Supporting Therapeutic Potential of ROCK Inhibition in Pulmonary Fibrosis
http://investors.kadmon.com/recent-press-releases/2017/03-28-2017-140425455
March 23 2017 - Systematic Review and Network Meta-analysis of Idiopathic Pulmonary Fibrosis Treatments
https://www.ncbi.nlm.nih.gov/pubmed/28287346
March 23 2017 - Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis
http://www.jmcp.org/doi/pdf/10.18553/jmcp.2017.23.3-b.s17
March 13 2017 - The Pulmonary Fibrosis Foundation Releases its New 'Pulmonary Fibrosis Information Guide'
March 13 2017 - AMPK negatively regulates tensin-dependent integrin activity
http://jcb.rupress.org/content/early/2017/03/10/jcb.201609066
March 10 2017 - Synairgen plc: Additional Positive Data in Lung Fibrosis
https://finance.yahoo.com/news/synairgen-plc-additional-positive-data-070000501.html
March 10 2017 - Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis
https://www.nature.com/articles/s41598-017-00270-0#Sec7
February 27 2017 - Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis
https://www.jci.org/articles/view/88896
February 23 2017 - Hsp90 regulation of fibroblast activation in pulmonary fibrosis
http://insight.jci.org/articles/view/91454
February 23 2017 - Global Blood Prices Offering At $24.50/Share
http://www.nasdaq.com/article/global-blood-prices-offering-at-2450share-20170223-02067
February 23 2017 - Mayo Clinic study finds link between biology of aging and idiopathic pulmonary fibrosis
February 22 2017 - Aeolus Initiates Phase 1 Study of AEOL 10150 in Healthy Normal Volunteers
February 18 2017 - FDA Confirms PROMETIC’S PBI-4050 IPF Clinical Trial Design
http://prometic.com/fda-confirms-prometics-pbi-4050-ipf-clinical-trial-design/
February 15 2017 - Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
February 14 2017 - TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts
https://www.nature.com/articles/srep42595
February 6 2017 - Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study
https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-017-0376-8
February 1 2017 - Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-017-0511-3
February 1 2017 - Confo Therapeutics is awarded EUR 2.6M in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology
http://files8.design-editor.com/93/9333026/UploadedFiles/B74CA458-41B2-C364-D6BE-DAB3742ADA82.pdf
January 31 2017 - The fibrogenic actions of lung fibroblast-derived urokinase: a potential drug target in IPF
January 29 2017 - Drug based on antibody discovered in sharks blood to be tested in humans
January 26 2017 - Precision Medicine: UAB Study Creates ‘Mini-Lung’ to Study Effect of Pulmonary Fibrosis Drugs
January 25 2017 - Increasing idiopathic pulmonary fibrosis research
http://www.news-medical.net/news/20170125/Increasing-idiopathic-pulmonary-fibrosis-research.aspx
January 18 2017 - Evotec, MaRS launch Fibrocor To Develop Therapeutics To Combat Fibrosis
January 18 2017 - European Commission grants orphan drug designation to ProMetic's PBI-4050 drug for the treatment of Alström Syndrome
http://finance.yahoo.com/news/european-commission-grants-orphan-drug-121500454.html
January 18 2017 - Nanoparticles from Car Tailpipes could Activate Viruses in the Lungs
http://labiotech.eu/nanoparticles-herpes-viruses-lungs/
January 13 2017 - Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
https://www.ncbi.nlm.nih.gov/pubmed/28085486
January 12 2017 - Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
http://onlinelibrary.wiley.com/doi/10.1002/rcr2.215/full
January 9 2017 - AdAlta Announces Positive Pre-clinical Data Showing Lead Drug Candidate Has Broad Fibrosis Treatment Potential
January 4 2017 - Aptuit and Chiesi Initiate Integrated Discovery Project to Identify Novel Compounds for the Treatment of Idiopathic Pulmonary Fibrosis
January 4 2017 - Competitors And Little Prospect Of Success For Roxadustat
http://seekingalpha.com/article/4034282-competitors-little-prospect-success-roxadustat
December 22 2016 - Antifibrotic drugs safe in idiopathic pulmonary fibrosis patients undergoing lung transplant
December 16 2016 - Preventing Telomere Shortening May Delay Some Chronic Diseases and Cancer
December 16 2016 - Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168552
December 8 2016 - miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
https://www.ncbi.nlm.nih.gov/pubmed/27942594
December 8 2016 - Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
https://insight.jci.org/articles/view/90558
December 5 2016 - JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.
https://www.ncbi.nlm.nih.gov/pubmed/27590145
December 2 2016 - Promedior Announces Completion of Patient Enrollment Milestones in Phase 2 Clinical Studies of PRM-151 in Both Idiopathic Pulmonary Fibrosis and Myelofibrosis
November 23 2016 - 3D-imaging technology to precisely spot deadly lung disease
November 22 2016 - Study Finds Cause of Pulmonary Fibrosis in Failure of Stem Cells That Repair Lungs
November 17 2016 - ProMetic's PBI-4050 Demonstrates Early Evidence of Efficacy in its Idiopathic Pulmonary Fibrosis ("IPF") Phase 2 Clinical Trial
http://www.theprovince.com/business/cnw/release.html?rkey=20161117C3527&filter=4007
November 15 2016 - Investigating the Molecular Roots of Lung Disease
http://news.feinberg.northwestern.edu/2016/11/investigating-the-molecular-roots-of-lung-disease/
November 10 2016 - Bristol-Myers' deepens focus on fibrosis with Nitto deal
http://www.reuters.com/article/us-bristol-myers-nitto-denko-idUSKBN1351CG
November 7 2016 - AdAlta and XL-protein Announce Collaboration to Develop a Long Acting Version of Its Lead Fibrosis Drug Candidate AD-114 Using PASylation® Technology
November 3 2016 - Windtree Therapeutics Preclinical Study Results Show Potential for KL4 Surfactant as Possible Medical Countermeasure to Radiation Exposure
October 28 2016 - COPD and idiopathic pulmonary fibrosis may have common genetic network
October 27 2016 - Benefit of Antifibrotics in Pulmonary Fibrosis Debated
http://www.medscape.com/viewarticle/871038
October 25 2016 - Veracyte Announces Launch of Envisia™ Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016
October 24 2016 - Efficacy of Ofev® (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
October 19 2016 - Study finds key regulator in pulmonary fibrosis
http://news.yale.edu/2016/10/19/study-finds-key-regulator-pulmonary-fibrosis
October 17 2016 - Indalo Therapeutics Formed by Merger of Antegrin and Cascadia
October 14 2016 - Understanding Lung Disease Mechanisms Using Effective Cell Analysis
October 12 2016 - Newcastle scientists working to crack the code of deadly lung disease idiopathic pulmonary fibrosis
October 4 2016 - HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway
https://www.ncbi.nlm.nih.gov/pubmed/27704718
September 7 2016 - Patara Pharma Announces Positive Phase 2 Results for the Treatment of Refractory Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis
September 6 2016 - Orphan Drug Designation in European Union for GLPG1690 in idiopathic pulmonary fibrosis
September 2 2016 - Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis
August 31 2016 - Boehringer Ingelheim expands partnership to study rare disease in real-world setting
August 30 2016 - Metformin attenuates lung fibrosis development via NOX4 suppression.
https://www.ncbi.nlm.nih.gov/pubmed/27576730
August 18 2016 - Physical Activity and Exertional Desaturation Are Associated with Mortality in Idiopathic Pulmonary Fibrosis
https://www.ncbi.nlm.nih.gov/pubmed/27548238
July 16 2016 - What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis
http://www.medscape.com/viewarticle/864581
July 15 2016 - Revealed: This under-the-radar biotech has blockbuster potential
http://www.fool.com.au/2016/07/15/revealed-this-under-the-radar-biotech-has-blockbuster-potential/
July 11 2016 - Fresh from Boehringer R&D tie-up, Inventiva to go public on Euronext
July 8 2016 - Australian Drug Discovery Company AdAlta, Announces IPO to Accelerate New Therapies for Lung Fibrosis
June 30 2016 - INMARKTM now enrolling: first study to evaluate the effect of OFEV® (nintedanib) on biomarkers reflecting the underlying fibrotic process in IPF patients
June 29 2016 - iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis
June 27 2016 - New analysis of INPULSIS™ trials demonstrates efficacy of OFEV® (nintedanib) across a range of IPF patients using broader diagnostic criteria
June 20 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis
June 16 2016 - Blade Therapeutics Raises $45 Million Series B Financing with Unparalleled Syndicate of VCs and Strategic Pharma Investors
June 16 2016 - Bellerophon Therapeutics (BLPH) Enrolls First Patient in Phase 3 INOvation-1
June 14 2016 - High endogenous activated protein C levels attenuates bleomycin-induced pulmonary fibrosis
http://onlinelibrary.wiley.com/doi/10.1111/jcmm.12891/full
June 9 2016 - Boehringer Ingelheim inks research pact with Harvard scientists to discover novel treatments for severe fibrotic diseases
http://www.pharmabiz.com/NewsDetails.aspx?aid=95625&sid=2
June 3 2016 - Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Idiopathic Pulmonary Fibrosis
http://news.sys-con.com/node/3837950
June 2 2016 - Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π
https://insight.jci.org/articles/view/85717
May 31 2016 - Recent advances in understanding idiopathic pulmonary fibrosis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890320/
May 31 2016 - Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis
May 23 2016 - Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877734/
May 23 2016 - Aeolus Pharmaceuticals to Present at LD Micro Invitational Conference
May 13 2016- Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis
http://www.nature.com/articles/srep25785
May 3 2016 - Data from Multiple Studies Evaluating Veracyte’s Genomic Classifiers for Lung Cancer and Idiopathic Pulmonary Fibrosis to Be Presented at ATS 2016
https://www.veracyte.com/media/press-releases/?id=201
May 1 2016 - Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
http://thorax.bmj.com/content/early/2016/04/21/thoraxjnl-2015-207429.long
April 22 2016 - Study finds shared network of genes in COPD and pulmonary fibrosis
http://news.yale.edu/2016/04/22/study-finds-shared-network-genes-copd-and-pulmonary-fibrosis
April 21 2016 - Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis
http://www.jmcp.org/doi/full/10.18553/jmcp.2016.22.4.414
April 21 2016 - Advanced 3-D imaging technique applied for the first time to deadly lung disease
http://www.eurekalert.org/pub_releases/2016-04/uos-a3i042016.php
April 14 2016 - Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832513/
April 13 2016 - Pulmonary Fibrosis Foundation Enrolls 1st Person in PFF Patient Registry, a Research Tool
April 7 2016 - Antegrin Expands Portfolio with Orally Available Integrin Antagonists
April 7 2016 - Vaccine improves fibrosis in mouse model of idiopathic pulmonary fibrosis
http://www.eurekalert.org/pub_releases/2016-04/joci-vif040616.php
April 6 2016 - Galapagos initiates a Phase 2a study with GLPG1690 in idiopathic pulmonary fibrosis patients
April 4 2016 - Starving immune cells prevents allergic reaction in lung
http://news.cornell.edu/stories/2016/04/starving-immune-cells-prevents-allergic-reaction-lung
March 23 2016 - Pulmatrix's iSPERSE 'Inhaled' Drug Delivery Technology Offers Hope to Patients with Pulmonary Lung Disease
March 22 2016 - Synairgen makes progress with lung drug
March 14 2016 - Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789787/
February 26 2016 - Analysis Confirms BI's OFEV Slows IPF Disease Progression
http://www.dddmag.com/news/2016/02/analysis-confirms-bis-ofev-slows-ipf-disease-progression
February 24 2016 - Galectin Therapeutics Receives U.S. Patent Allowance for GR-MD-02 to Treat Pulmonary Fibrosis
http://investor.galectintherapeutics.com/releasedetail.cfm?ReleaseID=956754
February 24 2016 - Mitophagy in macrophages is a key step toward pulmonary fibrosis
http://medicalxpress.com/news/2016-02-mitophagy-macrophages-key-pulmonary-fibrosis.html
February 18 2016 - Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases
February 12 2016 - Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury
http://www.nature.com/articles/srep21642
February 5 2016 - Websites For Idiopathic Pulmonary Fibrosis Are Inaccurate And Outdated
February 2 2016 - Candidate genes of idiopathic pulmonary fibrosis: current evidence and research
January 26 2016 - Idiopathic Pulmonary Fibrosis (IPF): OFEV▼® (nintedanib) is recommended for use within the NHS by the National Institute for Health and Care Excellence (NICE)
January 19 2016 - Patients with idiopathic pulmonary fibrosis acute exacerbations, immunosuppression at increased risk
January 6 2016 - Treat idiopathic pulmonary fibrosis, chronic lung disease with new approach?
January 5 2016 - Gilead Terminates Phase 2 Study of Simtuzumab in Patients With Idiopathic Pulmonary Fibrosis
December 16 2015 - Stonegate Capital Partners Initiates Coverage on Pulmatrix, Inc.
http://www.baystreet.ca/viewarticle.aspx?id=434760
December 15 2015 - Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of Nintedanib
December 15 2015 - Aeolus Announces $6.75 Million Private Placement Financing
December 8 2015 - Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to Phase 1 Clinical Trial
http://www.digitaljournal.com/pr/2768470
December 7 2015 - Manufacturer-Foundation partnership to increase PF research
December 1 2015 - Pulmonary Fibrosis Foundation Care Center Network Adds 19 New Sites
http://news.sys-con.com/node/3580079
November 30 2015 - Pulmonologists Report High Unmet Need For New Products To Treat Idiopathic Pulmonary Fibrosis (IPF), Despite The Recent Launches Of Roche's Esbriet And Boehringer Ingelheim's Ofev
http://news.sys-con.com/node/3577861
November 25 2015 - Organs on Chips
http://news.miami.edu/stories/2015/11/organs-on-chips.html
November 15 2015 - Diabetes raises risk for idiopathic pulmonary fibrosis
November 11 2015 - Afferent Pharmaceuticals Announces Phase 2 Clinical Trial with AF-219 in Cough in Idiopathic Pulmonary Fibrosis (IPF) Patients
October 13 2015 - Matrix metalloproteinases-10 levels predict clinical course of idiopathic pulmonary fibrosis
October 9 2015 - MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
http://www.nasdaq.com/press-release/medicinova-to-initiate-clinical-trial-of-mn001-tipelukast-in-ipf-20151009-00081
October 8 2015 - Delayed IPF Diagnosis Negatively Impacts Patients by Delaying Treatment According to Global Survey of Pulmonologists
October 2 2015 - Pulmonary Fibrosis Treatment Trickier Than Drug Trials Imply
http://www.medscape.com/viewarticle/852082#vp_2
October 1 2015 - New data demonstrate sustained long-term efficacy of OFEV®* on slowing disease progression and safety in patients with IPF
September 29 2015 - Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis
http://www.respiratory-research.com/content/16/1/120
September 24 2015 - Emerging themes in idiopathic pulmonary fibrosis
http://blogs.biomedcentral.com/on-medicine/2015/09/24/emerging-themes-idiopathic-pulmonary-fibrosis/
September 23 2015 - Roche says Esbriet boosts survival in pulmonary fibrosis
http://www.pmlive.com/pharma_news/roche_says_esbriet_boosts_survival_in_pulmonary_fibrosis_827775
September 15 2015 - Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570657/
September 11 2015 - Charleston researcher gets grant for pulmonary fibrosis therapy
http://www.postandcourier.com/article/20150910/PC05/150919936
September 11 2015 - Pulmatrix to Highlight PUR1900 Data at 2015 North American Cystic Fibrosis Conference
September 10 2015 - MediciNova's tipelukast Fast Track'd for ideopathic pulmonary fibrosis; shares up 17% premarket
September 9 2015 - Method of stem cell production may help improve IPF treatment
September 9 2015 - Texas A&M professors work toward curing, preventing fibrotic diseases
http://www.theeagle.com/news/local/texas-a-m-professors-work-toward-curing-preventing-fibrotic-diseases/article_edb3d84d-2f03-5298-b405-38a859280a7f.html
September 8 2015 - Promedior Announces Initiation of a Phase 2 Clinical Study of PRM-151 in Idiopathic Pulmonary Fibrosis (IPF)
September 4 2015 - NIH Awards Yale Researcher $3M to Study Genomics of Idiopathic Pulmonary Fibrosis
September 2 2015 - Pulmatrix Issued New Composition of Matter Patent Covering iSPERSE™ Technology
September 1 2015 - Bristol-Myers Buys Promedior for about $1.25 Billion, Beefs Up Fibrosis Drug Pipeline
August 20 2015 - Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice
http://www.nature.com/articles/srep13419
August 5 2015 - Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis
July 27 2015 - Increased protein turnover contributes to the development of pulmonary fibrosis
http://medicalxpress.com/news/2015-07-protein-turnover-contributes-pulmonary-fibrosis.html
July 21 2015 - MediciNova Announces Update on Development Plans for MN-001 in IPF
July 17 2015 - Idiopathic Pulmonary Fibrosis: New Guidelines Released
http://www.medscape.com/viewarticle/848220
July 15 2015 - Bristol-Myers looks to academia to double down on fibrosis R&D
http://www.fiercebiotech.com/story/bristol-myers-looks-academia-double-down-fibrosis-rd/2015-07-15
July 14 2015 - European Patent Office grants patent for treatment of Idiopathic Pulmonary Fibrosis to THERAMetrics
July 11 2015 - Idiopathic Pulmonary Fibrosis: Novel Treatment Promising
http://www.medscape.com/viewarticle/847832
July 7 2015 - Genentech’s Esbriet Safe and Tolerated By SSc-IPF Patients According To New Study http://sclerodermanews.com/2015/07/07/genentechs-esbriet-safe-tolerated-ssc-ipf-patients-according-new-study/
July 6 2015 - Diagnostic Imaging Tool to Assess Idiopathic Pulmonary Fibrosis Disease Progression Developed http://pulmonaryfibrosisnews.com/2015/07/06/diagnostic-imaging-tool-assess-idiopathic-pulmonary-fibrosis-disease-progression-developed/
July 1 2015 - CNIO researchers show that telomeres are linked to the origins of idiopathic pulmonary fibrosis
http://medicalxpress.com/news/2015-07-cnio-telomeres-linked-idiopathic-pulmonary.html
June 29 2015 - Thoracic Ultrasound Identifies Early Signs of Pulmonary Fibrosis in Systemic Sclerosis
June 23 2015 - Potential Treatment for Pulmonary Fibrosis
http://www.hcplive.com/medical-news/Potential-Treatment-for-Pulmonary-Fibrosis-
June 17 2015 - Study shows acute pulmonary fibrosis may respond to autoimmune disease therapy
June 12 2015 - UGA researchers find potential treatment for fatal lung diseases
http://www.eurekalert.org/pub_releases/2015-06/uog-urf061215.php
June 8 2015 - New approach for treating idiopathic pulmonary fibrosis
http://medicalxpress.com/news/2015-06-approach-idiopathic-pulmonary-fibrosis.html
May 28 2015 - Nanotechnology in respiratory medicine
http://www.respiratory-research.com/content/16/1/64/abstract
May 27 2015 - Second harmonic generation microscopy reveals altered collagen microstructure in usual interstitial pneumonia versus healthy lung
http://www.respiratory-research.com/content/16/1/61/abstract
May 21 2015 - RestorGenex Announces Data on the Effect of RES-529 in Pulmonary Fibrosis Models
http://finance.yahoo.com/news/restorgenex-announces-data-effect-res-100000726.html
May 18 2015 - New data and analyses confirm the efficacy and safety of OFEV® (nintedanib*) for the treatment of IPF beyond 52 weeks and for distinct subgroups
May 4 2015 - Mutations in two genes linked to familial pulmonary fibrosis and telomere shortening
April 22 2015 - Doctors in Galveston build lungs in laboratory
April 15 2015 - Exome Sequencing Study Links Variants in Two Genes to Familial Pulmonary Fibrosis
April 13 2015 - Limber Lungs: One Type of Airway Cell Can Regenerate Another Lung Cell Type
http://www.newswise.com/articles/view/632566/?sc=rsmn
April 3 2015 - Lung Transplant in an Older Pulmonary Fibrosis Patient Shown To Be a Success in UT Southwestern Case Study
March 27 2015 - Increased neoepitope concentrations linked with idiopathic pulmonary fibrosis progression
March 20 2015 - Scientists Grow 'Mini Lungs' for Cystic Fibrosis Research
http://www.laboratoryequipment.com/news/2015/03/scientists-grow-mini-lungs-cystic-fibrosis-research
March 20 2015 - Aeolus Receives Orphan Drug Designation From US FDA for AEOL 10150 for Treatment of Idiopathic Pulmonary Fibrosis
March 18 2015 - Promising New Target May Treat Pulmonary Fibrosis
http://www.newswise.com/articles/view/631328/?sc=rsmn
March 6 2015 - ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis
March 3 2015 - Outcomes of lung transplantations since implementation of need-based allocation system
http://medicalxpress.com/news/2015-03-outcomes-lung-transplantations-need-based-allocation.html
February 20 2015 - Individual Case Study Shows Bosentan Improves Pulmonary Fibrosis-Related Pulmonary Hypertension
February 10 2015 - MediciNova Announces FDA Approval of Protocol for Phase 2 Trial of MN-001 in IPF
http://globenewswire.com/news-release/2015/02/10/704829/10119397/en/MediciNova-Announces-FDA-Approval-of-Protocol-for-Phase-2-Trial-of-MN-001-in-IPF.html
February 6 2015 -Cynata Partners with the University of Western Australia to Boost Stem Cell Therapy for Lung Fibrosis
http://lungdiseasenews.com/2015/02/05/cynata-partners-with-the-university-of-western-australia-to-boost-stem-cell-therapy-for-lung-fibrosis/
February 4 2015 - ProMetic's PBI-4050 Cleared to Commence Clinical Trials in Patients With Idiopathic Pulmonary Fibrosis
February 3 2015 - Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.
http://www.ncbi.nlm.nih.gov/pubmed/25639750
January 19 2015 - OFEV® (nintedanib*) approved in the EU for the treatment of IPF
https://www.boehringer-ingelheim.com/news/news_releases/press_releases/2015/19_january_2015_ipf.html
January 12 2015 - Lung Fibrosis High Risk in Elderly Unveiled by University of Pittsburgh Team
http://pulmonaryhypertensionnews.com/2015/01/12/lung-fibrosis-high-risk-in-elderly-unveiled-by-university-of-pittsburgh-team/?utm_content=buffere8129&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer
January 9 2015 - Genkyotex Collects $21 Million to Fund NOX Inhibitors Research For IPF, Diabetic Nephropathy
http://pulmonaryfibrosisnews.com/2015/01/08/genkyotex-collects-21-million-to-fund-nox-inhibitors-research-for-ipf-diabetic-nephropathy/
January 8 2015 - Pacific Therapeutics CEO Provides Corporate Update To Shareholders
https://ca.finance.yahoo.com/news/pacific-therapeutics-ceo-provides-corporate-133000367--spt.html
January 5 2015 - Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases
http://green.tmcnet.com/news/2015/01/05/8130120.htm
November 22 2014 - Nintedanib* receives positive CHMP opinion in European Union for the treatment of IPF
http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=104225
November 20 2014 - Fat a culprit in fibrotic lung damage
http://medicalxpress.com/news/2014-11-fat-culprit-fibrotic-lung.html
November 19 2014 - An IPF Game-Changer: A Primer on the Newly Approved Drugs
http://www.medscape.com/viewarticle/835076#vp_2
November 7 2014 - Does Oxygen Supplementation Help In Pulmonary Fibrosis? Researchers Are Set to Find Out
November 6 2014 - Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis
http://www.biomedcentral.com/1471-2466/14/172/abstract
November 3 2014- Bristol-Myers beefs up fibrosis pipeline with $444M option deal
http://www.fiercebiotech.com/story/bristol-myers-beefs-fibrosis-pipeline-444m-option-deal/2014-11-03
October 30 2014 - New Familial, Sporadic Idiopathic Pulmonary Fibrosis Peripheral Blood Test Could Make Diagnosis Easier
October 28 2014 - Physician Views: The idiopathic pulmonary fibrosis (IPF) market – let battle commence
http://www.firstwordpharma.com/node/1242020#axzz3HMwoyHXw
October 28 2014 - Pharma Start-up Lung Therapeutics, Inc. Achieves Significant Funding to Address Unmet Needs in Lung Injury and Disease
http://finance.yahoo.com/news/pharma-start-lung-therapeutics-inc-110000789.html
October 23 2014 - ProMetic Will Explore PB-4050 Potential as Idiopathic PF Treatment
October 21 2014 - ProMetic Will Explore PB-4050 Potential as Idiopathic PF Treatment
October 18 2014 - Parion Sciences Announces $15.6 Million in Grant Support for Pulmonary Research Program
October 16 2014 - Reversing Idiopathic Pulmonary Fibrosis
http://www.biosciencetechnology.com/articles/2014/10/reversing-idiopathic-pulmonary-fibrosis
October 15 2014 - FDA approves Esbriet to treat idiopathic pulmonary fibrosis
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418991.htm
October 15 2014 - FDA approves Ofev to treat idiopathic pulmonary fibrosis
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm
October 7 2014 - Allied Minds Announces the Launch of Novare Pharmaceuticals, a Biotech Company Focused on Developing Therapeutics that Modulate RHAMM
October 3 2014 - Coating nanotubes with aluminum oxide lowers risk of lung injury
http://phys.org/news/2014-10-coating-nanotubes-aluminum-oxide-lowers.html
October 2 2014 - Promedior Announces Presentation of Retrospective Quantitative Imaging Analysis of Phase 1b Data in Idiopathic Pulmonary Fibrosis
http://www.promedior.com/news/releases/2014%200922%20PRM-151%20Data%20at%20ICLAF.html
September 3 2014 - Rhizen Pharmaceuticals S.A. to present preclinical data of their first-in-class inflammation assets, RP6503 and RP3128 for treatment of various respiratory diseases
http://finance.yahoo.com/news/rhizen-pharmaceuticals-present-preclinical-data-090000970.html
September 1 2014 - MediciNova to Present Data on MN-001 (tipelukast) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) During the 18th International Colloquium on Lung and Airway Fibrosis (ICLAF)
https://in.finance.yahoo.com/news/medicinova-present-data-mn-001-230000102.html
August 26 2014 - ImmuneWorks has a lung transplant therapy in the works http://medcitynews.com/2014/08/immuneworks-lung-transplant-therapy-works/
August 24 2014 - Roche to buy biotech firm InterMune for $8.3B
August 24 2014 - New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein, PhD to Advance Pulmonary Fibrosis Research
http://finance.yahoo.com/news/amsterdam-sciences-continues-pact-dr-113000864.html
August 21 2014 - UCSF Researchers Win Funding for Heart, Lung and Blood Studies
http://www.ucsf.edu/news/2014/08/116791/ucsf-researchers-win-funding-heart-lung-and-blood-studies
August 19 2014 - Differential diagnoses create challenges with IPF
http://www.modernmedicine.com/modern-medicine/news/differential-diagnoses-create-challenges-ipf
August 12 2014 - FDA approves donor lung preservation device that may result in more lung transplants
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409488.htm
August 11 2014 - Idiopathic Pulmonary Fibrosis: Hope, At Last
http://www.biosciencetechnology.com/articles/2014/08/idiopathic-pulmonary-fibrosis-hope-last
July 24 2014 - Guidelines in Pulmonary & Critical Care
July 22 2014 - Boehringer Ingelheim Establishes a Research Alliance
http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2014/22_july_2014_toronto.html
July 9 2014 - Combination Treatment for Pulmonary Fibrosis Demonstrates Significant Disease Improvement in Pre-Clinical Trial
http://online.wsj.com/article/PR-CO-20140709-906208.html
July 3 2014 - PDUFA date set for pirfenidone NDA
http://seekingalpha.com/news/1829115-pdufa-date-set-for-pirfenidone-nda
July 2 2014 - U.S. FDA Accepts NDA Filing for Boehringer Ingelheim's Investigational Nintedanib and Grants Priority Review Designation for the Treatment of Idiopathic Pulmonary Fibrosis
http://www.prnewswire.com/news-releases/us-fda-accepts-nda-filing-for-boehringer-ingelheims-investigational-nintedanib-and-grants-priority-review-designation-for-the-treatment-of-idiopathic-pulmonary-fibrosis-265526741.html?utm_content=buffer5c116&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer
June 25 2014 - Boehringer Ingelheim Announces Nintedanib Expanded Access Program (EAP) for Patients with Idiopathic Pulmonary Fibrosis
http://www.prnewswire.com/news-releases/boehringer-ingelheim-announces-nintedanib-expanded-access-program-eap-for-patients-with-idiopathic-pulmonary-fibrosis-264415041.html
June 23 2014 - Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis
http://www.marketwatch.com/story/curis-announces-investigational-new-drug-application-filing-by-roche-to-initiate-a-phase-2-study-of-erivedger-vismodegib-in-idiopathic-pulmonary-fibrosis-2014-06-23
http://www.wallstreet-online.de/nachricht/6822464-copd-foundation-releases-groundbreaking-cope-survey-results-low-patient-awareness-about-copd-exacerbations-poses-barrier-to-effective-management
June 19 2014 - Every Breath Counts - IPF - (Movie, Show, Documentary - 1hr.)
http://everybreathcountsfilm.com/
June 16 2014 - New discoveries in the genetics of lung health
http://phys.org/wire-news/164358407/new-discoveries-in-the-genetics-of-lung-health.html
June 11 2014 - The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry
June 5 2014 - EMA accepts marketing authorisation application for nintedanib* in IPF https://ca.finance.yahoo.com/news/ema-accepts-marketing-authorisation-application-060000755.html
May 27 2014 - InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF
https://ca.finance.yahoo.com/news/intermune-announces-resubmission-nda-pirfenidone-110000354.html
May 21 2014 - Lanthio Pharma receives Dutch Government loan of up to €3.6 million to develop novel therapy for lung fibrosis
http://www.marketwatch.com/story/lanthio-pharma-receives-dutch-government-loan-of-up-to-36-million-to-develop-novel-therapy-for-lung-fibrosis-2014-05-21
May 19 2014 - FibroGen Announces Phase 2 Data Supporting Longer-Term Safety and Efficacy Profile of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis
http://finance.yahoo.com/news/fibrogen-announces-phase-2-data-161400031.html
May 18 2014 - Nintedanib Slows IPF Progression
http://www.medpagetoday.com/MeetingCoverage/ATS/45834
May 18 2014 - Antioxidant No Help in IPF
http://www.medpagetoday.com/MeetingCoverage/ATS/45835
May 18 2014 - Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine
May 15 2014 - IPF Takes Stage at ATS
http://www.medpagetoday.com/MeetingCoverage/ATS/45781
May 13 2014 - Genoa Pharmaceuticals to Present at the Annual American Thoracic Society International Conference
https://ca.finance.yahoo.com/news/genoa-pharmaceuticals-present-annual-american-040100711.html
May 8 2014 - Preliminary Data Supporting Veracyte Molecular Classifier for Idiopathic Pulmonary Fibrosis (IPF) Diagnosis to be Presented at ATS 2014
http://online.wsj.com/article/PR-CO-20140507-908478.html
May 7 2014 - Protein molecule may improve survival in deadly lung disease
medicalxpress.com/news/2014-05-protein-molecule-survival-deadly-lung.html
April 29 2014 - Patient Receives One of the World’s Quickest Lung Transplants
www.newswise.com/articles/view/617150/?sc=rsmn
April 25 2014 - 'Beneficial inflammation' may promote healing in pulmonary fibrosis
www.sciencecodex.com/beneficial_inflammation_may_promote_healing_in_pulmonary_fibrosis-132472
April 21 2014 - Genoa Pharmaceuticals, McMaster University report additional benefits of GP-101 for IPF patients
April 15 2014 - A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant
April 10 2014 - Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis
March 25 2014 -Auspex Announces The Issuance Of Patents On Deuterium-Containing Form Of Pirfenidone (SD-560)
ca.finance.yahoo.com/news/auspex-announces-issuance-patents-deuterium-200100971.html
March 17 2014 - New research links body clocks to chronic lung diseases
medicalxpress.com/news/2014-03-links-body-clocks-chronic-lung.html
March 9 2014 - Lung regeneration comes closer to reality
www.aninews.in/newsdetail9/story158584/lung-regeneration-comes-closer-to-reality.html
February 25 2014 - InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
ca.finance.yahoo.com/news/intermune-reports-phase-3-ascend-120000665.html
February 18 2014 - Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(14)70011-6/fulltext
February 12 2014 - Cedars-Sinai research team receives grant to develop treatment for idiopathic pulmonary fibrosis
January 30 2014 -iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline
January 24 2014 - Sanofi forms two-year rare disease partnership with MabImprove
January 15 2014 - Scientists discover new cellular process leading to lung fibrosis
http://medicalxpress.com/news/2014-01-scientists-cellular-lung-fibrosis.html
January 10 2014 - The ATS Foundation, Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation Award $100,000 to Chi Hung, MD to Study Idiopathic Pulmonary Fibrosis.
January 8 2014 - Scientists offers way to disrupt fibrosis
http://www.thealmagest.com/scientists-offers-way-disrupt-fibrosis/9335
January 7 2014 - UGA research creates hope for tissue fibrosis therapeutics
http://onlineathens.com/health/2014-01-06/uga-research-creates-hope-tissue-fibrosis-therapeutics
January 6 2014 - Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway
January 5 2014 - A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
http://bmjopenrespres.bmj.com/content/1/1/e000007.full
December 18 2013 - Improving Endurance in Idiopathic Pulmonary Fibrosis Patients
December 18 2013 - UCD Conway Institute researchers identify potential biomarker of idiopathic pulmonary fibrosis
http://www.news-medical.net/news/20131218/UCD-Conway-Institute-researchers-identify-potential-biomarker-of-idiopathic-pulmonary-efac81brosis.aspx
December 14 2013 - 6MWT diction change could raise sequence utility
http://healthmedicinet.com/6mwt-wording-change-could-enhance-serial-utility/
December 10 2013 - TNF-α Accelerates the Resolution of Established Pulmonary Fibrosis in Mice by Targeting Pro-Fibrotic Lung Macrophages
December 02 2013 - Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
http://www.eurekalert.org/pub_releases/2013-12/foas-oli120213.php
December 01 2013 - Human stem cells converted to functional lung cells
http://www.eurekalert.org/pub_releases/2013-12/cumc-hsc112713.php
November 30 2013 - Keyhole lung transplant performed on 60-year-old in Chennai
November 27 2013 - FibroGen Announces Observations of Possible Disease Stabilization and Improvement in Interim Analysis of Phase 2 Study of FG-3019
November 15 2013 - Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus
http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=80738#.UoY1l8so5EY
November 10 2013 - Research by Saint Louis University scientists offers way to disrupt fibrosis
http://www.eurekalert.org/pub_releases/2013-11/slu-rbs110713.php
November 4 2013 - Development Plan for PTL-202, a Treatment for Progressive Organ Scarring, a $1.1 Billion Opportunity
http://www.baystreet.ca/viewarticle.aspx?id=409245
October 28 2013 - Ambrisentan (Letairis) stopped early in IPF trial (Annals Int Med)
October 21 2013 - Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study
http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70191-7/fulltext
October 18 2013 - UW researchers to test novel therapy for idiopathic pulmonary fibrosis
http://engage.washington.edu/site/PageNavigator/UWMedicine/OnlineNews/OnlineNews_10_18_2013.html
October 13 2013 - Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice
http://www.nature.com/ncomms/2013/131011/ncomms3563/full/ncomms3563.html
October 11 2013 - UAB gets $9.7 million to find treatments for deadly lung disease pulmonary fibrosis
October 10 2013 - Finding cellular causes of lung-hardening disease
http://medicalxpress.com/news/2013-09-cellular-lung-hardening-disease.html
October 9 2013- Promedior Initiates Phase 2 Clinical Study of PRM-151 in Myelofibrosis
October 3 2013 - Newly identified biomarkers help predict outcome in deadly lung disease
http://www.eurekalert.org/pub_releases/2013-10/yu-nib100113.php
September 29 2013 - Trial to determine if stem cells can help with rare lung disease
http://www.miamiherald.com/2013/09/28/3658088/trial-to-determine-if-stem-cells.html
September 28 2013 - Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future
http://err.ersjournals.com/content/22/129/281.full
September 2 2013 - New pathway to treat colorectal cancer, pulmonary fibrosis
http://israel21c.org/health/new-pathway-to-treat-colorectal-cancer-pulmonary-fibrosis/
September 2 2013 - Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR™ trial, and their respiratory pipeline products in COPD, asthma, IPF and lung cancer at ERS 2013
August 8 2013 - Aradigm Awarded NIH Grant to Investigate New Methods of Diagnoses of Aspirations of Gastrointestinal Contents into the Respiratory Tract with Scientists at UC San Francisco
http://finance.yahoo.com/news/aradigm-awarded-nih-grant-investigate-110000078.html
August 5 2013 - Oral N-acetylcysteine (NAC) reduces COPD exacerbations in RCT (Chest)
August 3 2013 - Ambrisentan found ineffective against idiopathic pulmonary fibrosis
http://www.2minutemedicine.com/ambrisentan-found-ineffective-against-idiopathic-pulmonary-fibrosis/
July 29 2013 - UVM hosts conference on revolutionary cell therapies to treat deadly lung diseases
July 15 2013 - Compugen Announces US Patent Allowance for Drug Candidate Recently Presented at 2013 American Thoracic Society Meeting
July 11 2013 - ProMetic's Lead Drug Candidate, PBI-4050, on Track to Enter Clinical Trial Program in September 2013
http://online.wsj.com/article/PR-CO-20130711-904453.html?mod=googlenews_wsj
July 7 2013 - University of Washington's first double lung transplant doing great 2 decades later
July 2 2013 - New procedure to treat acid reflux can prevent chronic rejection in lung transplant patients
June 28 2013 - New procedure to treat acid reflux can prevent chronic rejection in lung transplant patients
June 28 2013 - Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70105-X/fulltext
June 24 2013 - Verona Pharma confirms 1st patient dosed with VRP700
June 12 2013 - GPs urged to suspect pulmonary fibrosis in older patients with persistent cough
June 7 2013 - Genoa, McMaster University reveal findings of GP-101 in pulmonary fibrosis treatment
May 24 2013 - Reflux Medicine Boosts Survival in Lung Disease
http://www.medpagetoday.com/MeetingCoverage/ATS/39379
May 22 2013 - Promedior Presents Encouraging Results from Clinical Study of PRM-151 in Patients with Idiopathic Pulmonary Fibrosis
http://www.promedior.com/news/releases/2013%200522%20Promedior%20PRM-151%20IBS%20Ph1b%20Results.html
May 21 2013 - Genetic variation among patients with pulmonary fibrosis associated with improved survival
http://www.eurekalert.org/pub_releases/2013-05/tjnj-gva051613.php
May 21 2013 - Race Horses May Hold Key to Cure for Deadly Lung Disease Killing Humans, Horses, Other Domestic Animals
http://news.yahoo.com/race-horses-may-hold-key-cure-deadly-lung-223600055.html
May 16 2013 - Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients with IPF at the ATS 2013 Annual Meeting
http://online.wsj.com/article/PR-CO-20130516-909919.html?mod=googlenews_wsj
May 8 2013 - US/EU Idiopathic pulmonary fibrosis drug sales "to rise 86.6%/year to 2017"
May 6 2013 - Ambrisentan Fails in Lung Fibrosis
http://www.medpagetoday.com/Pulmonology/GeneralPulmonary/38925
April 29 2013 - Interventions to Improve Symptoms, Quality of Life in Fibrotic ILD: Do They Work?
April 17 2013 - Study shows TOLLIP gene variant is linked to increased mortality risk in IPF patients
April 15 2013 - Genetic variation contributes to pulmonary fibrosis risk
http://www.eurekalert.org/pub_releases/2013-04/uocd-gvc041513.php
April 11 2013 - Mast cells have critical role in initializing pulmonary fibrosis
http://www.eurekalert.org/pub_releases/2013-04/mali-mch041113.php
April 2 2013 - BioGenerator Invests in Antegrin
http://interact.stltoday.com/pr/business/PR040213105312399
March 27 2013 - Pulmonary Fibrosis Foundation Announces Open Registration For International Health Care Conference On Pulmonary Fibrosis
March 25 2013 - Scientists identify potential treatment for idiopathic pulmonary fibrosis http://www.news-medical.net/news/20130325/Scientists-identify-potential-treatment-for-idiopathic-pulmonary-fibrosis.aspx
March 21 2013 - New procedure gives hope to lung transplant patients - video! http://www.today.com/video/today/51270034#51270034
March 14 2013 - Oldest patient in Ky. to receive lung transplant gets new lease on life
February 22 2013 - Inhibition" of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
http://www.jci.org/articles/view/66700
January 17 2013 - Game changing therapy for Idiopathic Pulmonary Fibrosis now available in Canada.
January 16 2013 - Genoa Pharmaceuticals and McMaster University to collaborate on Idiopathic Pulmonary Fibrosis Research
January 10 2013 - Does GERD really cause chronic cough? (Chest)
http://pulmccm.org/2013/outpatient-pulmonology-review/does-gerd-really-cause-chronic-cough-chest/
January 6 2013 - PANTHER-IPF negative, stopped early for harm from steroids, Imuran in IPF (RCT, NEJM)
January 3 2013 - Celtaxsys Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary Inflammation
December 24 2012 GERD Treatment Improves Survival in Idiopathic Pulmonary Fibrosis?
http://pulmccm.org/2012/interstitial-lung-disease-review/gerd-therapy-associated-with-survival-in-ipf-ajrccm/
November 14 2012 New lung tissue growth can occur in adults, defying previous belief (NEJM)
http://pulmccm.org/2012/lung-cancer-review/lung-regeneration-after-damage-defying-previous-belief/
November 8 2012 Genoa Pharmaceuticals announces $1.2M Financing - Leveraging expertise to advance GP-101 for treatment of Idiopathic Pulmonary Fibrosis
http://genoapharma.com/news-and-events/11-08-2012-genoa-pharmaceuticals-announces-12m-financing/
October 22 2012 Chinese Herbs Show Promise for Lung Cancer, Flu, and Idiopathic Pulmonary Fibrosis
http://www.sciencenewsline.com/summary/2012102206520014.html
October 9 2012 Cardiac and Pulmonary Researchers Team Up to Test Stem Cell Therapy for Fatal Lung Disease
September 25 2012 Recruitment complete for two pivotal Phase III studies of nintedanib*in patients with idiopathic pulmonary fibrosis
http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2012/24_september_2012ipf.html
September 17 2012 Thalidomide May Help Patients With Deadly Lung Disease
September 5 2012 FibroGen Announces Presentation of Updated Results at European Respiratory Society Annual Congress
September 3 2012 InterMune, Inc. : InterMune Reports New Analyses from the RECAP Study of Esbriet (pirfenidone) at ERS
August 27 2012 InterMune Announces Presentations of New Research in IPF at ERS
August 23 2012 Science: Human lungs brush out intruders
http://www.eurekalert.org/pub_releases/2012-08/aaft-hl082012.php
July 31 2012 FibroGen's FG-3019 Granted U.S. Orphan Drug Designation for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
http://www.fibrogen.com/press/release/pr_1343708794
July 25 2012 Stem-cell complaint against Fort Myers physician to go to trial
July 12 2012 GSK warns on Gilead lung drug for some patients
http://www.reuters.com/article/2012/07/12/us-glaxosmithkline-volibris-idUSBRE86B0XZ20120712
June 28 2012 Grasping at Straws while Gasping for Air
http://sciencelife.uchospitals.edu/2012/06/28/grasping-at-straws-while-gasping-for-air/
June 20 2012 MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)
May 31 2012 Scientists identify agent that can block fibrosis of skin, lungs
http://medicalxpress.com/news/2012-05-scientists-agent-block-fibrosis-skin.html
May 21 2012 Stopping cell migration may help block fibrosis and the spread of cancer
http://medicalxpress.com/news/2012-05-cell-migration-block-fibrosis-cancer.html
May 19 2012 Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
http://www.nejm.org/doi/full/10.1056/NEJMoa1113354?query=featured_home
May 3 2012 FibroGen Announces Promising Preliminary Data from an Open-label Phase 2 Study to Evaluate the Safety and Efficacy of FG-3019 in Individuals with Idiopathic Pulmonary Fibrosis (IPF) and Provides Program Update
April 10 2012 Researchers find critical regulator to tightly control deadly pulmonary fibrosis
http://www.eurekalert.org/pub_releases/2012-04/gsu-rfc041012.php
March 30 2012 2012 Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs
March 7 2012 Cancer drug may stymie lung disease
http://www.futurity.org/health-medicine/cancer-drug-may-stymie-lung-disease/comment-page-1/#comment-47881
March 7 2012 Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
February 28 2012 Delivery and Safety of Inhaled Interferon- in Idiopathic Pulmonary Fibrosis
http://online.liebertpub.com/doi/abs/10.1089/jamp.2011.0919
February 28 2012 Bristol-Myers Squibb and Duke Translational Medicine Institute Form Strategic Relationship to Broaden Interactions - First Project Will be to Develop and Implement Protocol for Phase II Study in Idiopathic Pulmonary Fibrosis
February 13 2012 STX-100 - One Of The VCs Behind Today's Big Biotech Deal Tells His Story
http://www.forbes.com/sites/brucebooth/2012/02/14/return-of-the-jedi-stromedix-acquired-by-biogen/
February 1 2012 Canada Drugs Online Stocks Pirfenidone, the Preferred IPF Medication http://www.prweb.com/releases/pirfenidone/canadadrugsonline/prweb9155255.htm
January 20 2012 Carolus Therapeutics Reports Publication of Preclinical Data for CT-2009 Supporting Development in Acute Lung Injury
January 12 2012 Pacific Therapeutics Ltd. Provides Update on the Development of Lead Drug Candidate PTL-202
http://www.usetdas.com/TDAS/NewsArticle.aspx?NewsID=18877
January 6 2012 Statins may increase risk of interstitial lung abnormalities in smokers
http://www.eurekalert.org/pub_releases/2012-01/ats-smi010312.php
December 22 2011 Coalition for Pulmonary Fibrosis Kicks Off "Lips for a Cure" Promotional Campaign With Mary Kay Products
December 15 2011 IQWIG Publishes Early Benefit Assessment for Pirfenidone
http://www.marketwatch.com/story/iqwig-publishes-early-benefit-assessment-for-pirfenidone-2011-12-15
December 14 2011 Pacific Therapeutics Ltd. Announces Closing of Non-Brokered Private Placement
http://www.pacifictherapeutics.com/products-ptl202.html
December 13 2011 Woman received lung transplant through new UMD procedure
December 12 2011 Stanford-researchers reveal how mechanical forces contribute to scarring
December 6 2011 Pulmonary Fibrosis Foundation's Inaugural IPF Summit Receives High Accolades From Pulmonary Fibrosis Community
December 1 2011 New insights come from tracing cells that scar lungs
http://www.eurekalert.org/pub_releases/2011-12/dumc-nic120111.php
November 28 2011 Roots of Acute Worsening in ILD Elusive
November 22 2011 Local doctor co-authors stem cell study
November 10 2011 Idiopathic Pulmonary Fibrosis Drug Market to Grow to $4.6 Billion in 2020
October 27 2011 Stem cells repair lung damage after flu infection
http://www.eurekalert.org/pub_releases/2011-10/cp-scr102111.php
October 25 2011 Blood Proteins Predict Survival in Idiopathic Pulmonary Fibrosis, Team Finds
http://www.sciencedaily.com/releases/2011/10/111025163123.htm
October 21 2011 Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful
http://www.nih.gov/news/health/oct2011/nhlbi-21.htm
October 18 2011 Cough May Warn of Danger for Patients with Lung-Scarring Disease
October 17 2011 Pulmonary Fibrosis Foundation Launches Research Fund to Cure Pulmonary Fibrosis
October 12 2011 Stem Cells, Signaling Pathways Identified in Lung Repair
http://www.sciencedaily.com/releases/2011/10/111011121418.htm
October 12 2011 Pulmonary Fibrosis Foundation to Fund Further Therapeutic Evaluation Studies for Compugen-Discovered Drug Candidate
October 5 2011 Progression of Lung Fibrosis Blocked in Mouse Model
http://health.ucsd.edu/news/2011/Pages/10-05-pulmonary-fibrosis.aspx
September 26 2011 New Data Demonstrate Longer-Term Safety Profile of Esbriet (Pirfenidone)
September 24 2011 Cancer Drug Equally Effective In Treating Scleroderma, Pulmonary Fibrosis
September 21 2011 China SFDA approves F647/ Pirfenidone for the treatment of Idiopathic Pulmonary Fibrosis
http://www.gnipharma.com/english/news/download/TSE20110922.pdf
September 21 2011 Drug Shows Promise Against Deadly Lung Disease
http://news.health.com/2011/09/21/drug-shows-promise-against-deadly-lung-disease/
September 20 2011 Estrogen treatment may help reverse severe pulmonary hypertension
http://www.uclahealth.org/body.cfm?id=561&action=detail&ref=1738
September 19 2011 Biotechnology Firm ImmuneWorks Supports Pulmonary Fibrosis Week by Increasing National Recruitment Efforts to Enroll Idiopathic Pulmonary Fibrosis (IPF) Patients in Clinical Trial
September 12 2011 InterMune Announces Launch of Esbriet (pirfenidone) in Germany
http://phx.corporate-ir.net/phoenix.zhtml?c=100067&p=irol-newsArticle&ID=1605704&highlight=
September 06 2011 IntelGenx to Present at the Rodman & Renshaw 13th Annual Healthcare Conference in New York
Drug = INT0024 Testing Information at:
http://www.intelgenx.com/_assets/pdf/Intelgenx-FactSheet.pdf
August 29 2011 Actelion's Mid-stage Study Of IPF Drug Macitentan Fails To Meet Primary Goal
http://www.rttnews.com/Content/BiotechStory.aspx?Id=1701621&Category=ClinicalTrial
August 26 2011 Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Assessment and Market Forecasts to 2018
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=46198
August 25 2011 Stem cells show promise against respiratory diseases
http://www.thehindu.com/health/medicine-and-research/article2396850.ece
August 23 2011 GeNO LLC Receives Federal Grant To Advance Studies of Inhaled Nitric Oxide Product for the Treatment of Chronic Pulmonary Diseases
http://www.sys-con.com/node/1954269
August 18 2011 Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders - Preliminary results.
http://7thspace.com/headlines/391876/utility_of_a_simplified_ultrasound_assessment_to_assess_interstitial_pulmonary_fibrosis_in_connective_tissue_disorders___preliminary_results.html connective_tissue_disorders___preliminary_results.html
August 15 2011 Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
(TRANSLATION) De Telegraaf (The Netherlands) Dutch Newspaper
Monday August 15 2011, 12:24
Creating stem cells from humans a step closer
LONDON - Researchers from the Erasmus University in Rotterdam have discovered how a protein causes embryonic stem cell can develop into any type of cell in the body. This discovery, made in mice, is an important step for creating new cells from adult cells.
This is useful because researchers prefer to avoid the use of embryonic stem cells. That stem cells derived from embryos. There are not too many of them available and there are also moral objections.
From adult body cells, it is theoretically possible to create stem cells, but the problem is that these stem cells do not forget where they come from. "For example, stem cells need to have a defect in the heart muscle to recover, it is difficult to get cells from the heart to get. You do not just happen. It would be useful for such purpose to use skin cells and transform into stem cells. But that skin cells do not forget that they once were and skin are not just to transform into heart cells that can help. That's a problem, "explained Derk ten Berge stem cell biologist from Monday.
With the discovery of the Wnt protein, the researchers hope to circumvent this problem. "If we can make embryonic stem cells of the body's cells, which then can be used anywhere, we do not need stem cells from embryos. It is possible that every human body's tissues can be grown, "said Ten Berge.
The researchers published their findings this week in the scientific journal Nature Cell Biology.
The Publication in Nature Cell Biology
http://www.nature.com/ncb/journal/vaop/ncurrent/full/ncb2314.html
August 5 2011InterMune Loss Rise, Costs Flare Up (Ascend Trial news)
http://www.dailymarkets.com/stock/2011/08/05/intermune-loss-rise-costs-flare-up/
August 4 2011InterMune Reports Second Quarter 2011 Financial Results and Business Highlights (Named Patient Access Program (NPP) for Europe)
July 26 2011 Artificial Lung Mimics Real Organ's Design and Efficiency: Small Device Works With Air, Pure Oxygen Not Needed
http://www.sciencedaily.com/releases/2011/07/110725123659.htm
July 20 2011 Heartburn Treatment May Extend Survival in Idiopathic Pulmonary Fibrosis (IPF) Patients
http://www.sciencedaily.com/releases/2011/07/110719151913.htm
July 12 2011 Bi-Partisan Congressional Coalition Reaches Across the Aisle to Introduce the Pulmonary Fibrosis Research Enhancement Act in the U.S. Congress
http://www.digitaljournal.com/pr/360485
July 12 2011 License Agreement for the Sale of Pirfenidone (Pirespa) in South Korea With Ildong Pharmaceutical
http://pharmalive.com/News/index.cfm?articleid=793033&categoryid=10
July 7 2011 InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF
http://phx.corporate-ir.net/phoenix.zhtml?c=100067&p=irol-newsArticle&ID=1583340&highlight=
July 6 2011 Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmonary Anti-Fibrotic Effect Demonstrated
http://olgc.client.shareholder.com/releasedetail.cfm?ReleaseID=589281
July 5 2011 CPF Announces Dates for National Pulmonary Fibrosis Awareness Week as Part of 10th Anniversary
http://www.reuters.com/article/2011/07/05/idUS148785+05-Jul-2011+PRN20110705
June 30 2011 Many More Lungs Suitable for Transplantation
http://www.sciencedaily.com/releases/2011/06/110630111534.htm
June 27 2011 Duke researchers learn how lung fibrosis begins and could be treated
http://www.eurekalert.org/pub_releases/2011-06/dumc-drl062311.php
June 22 2011 Pulmonary Fibrosis and Lung Transplant
http://health.usi.edu/cont_ed/PulmonaryFibSym2011/Reynolds PPT.pdf
June 8 2011 Research: A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode (Please open provisional PDF near he bottom)
http://respiratory-research.com/content/12/1/73/abstract
June 4 2011 U.S. to Lower Public Insurance Premiums for People with CF and other Pre-Existing Conditions
June 2 2011 Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01366209
May 25 2011 InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
http://finance.yahoo.com/news/InterMune-to-Provide-Overview-prnews-376568154.html?x=0&.v=1
May 16 2011 Promedior Presents Clinical Data for PRM-151 (rhPTX-2) in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2011 - Data Highlights Safety and Biomarker Activity in Patients with IPF
http://www.promedior.com/news/pressReleases/2011_0516_press.html
May 16 2011 InterMune Announces Presentation of Positive Pirfenidone Data at the International Conference of the American Thoracic Society (ATS) - New ASCEND trial
http://phx.corporate-ir.net/phoenix.zhtml?c=100067&p=irol-newsArticle&ID=1563825&highlight=
May 13 2011 Pirfenidone Phase 3 Results Published Today in The Lancet
May 12 2011 Evidence for Human Lung Stem Cells
http://www.usnews.com/mobile/articles_mobile/discovery-of-lung-stem-cells-may-herald-new-treatments
May 5 2011 Promedior to Present Clinical Data for PRM-151 (rhPTX-2) in Idiopathic Pulmonary Fibrosis at ATS 2011
April 20 2011 NIH News - Common genetic variant linked to pulmonary fibrosis risk
http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2785
April19 2011 Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
http://www.amirapharm.com/articles/AM152 Orphan Drug.html
April 7 2011 UVM to conduct clinical trial for new idiopathic pulmonary fibrosis treatment
www.vermontbiz.com/news/april/uvm-conduct-clinical-trial-new-idiopathic-pulmonary-fibrosis-treatment
April 1 2011 Revised Lung Allocation System Transformed Transplantation Dynamics
March 30 2011 MUSC launches new lung transplant program
http://www.live5news.com/story/14317398/musc-launches-new-lung-transplantation-program
March24 2011 A simple, yet promising treatment for pulmonary fibrosis
March23 2011 MicroRNAs: A potential new frontier for medicine
March13 2011 Hope stems for man with lung disease - (Hindustan Times)
http://www.hindustantimes.com/Hope-stems-for-man-with-lung-disease/Article1-672813.aspx
March10 2011 Shedding Some Light into Mystery of Idiopathic Pulmonary Fibrosis
http://www.prlog.org/11363837-shedding-some-light-into-mystery-of-idiopathic-pulmonary-fibrosis.html
March 8 2011 Fibrogen -Phase 2 study of FG-3019 for the treatment of idiopathic pulmonary fibrosis (IPF)
March 7 2011 Gilead Sciences gets rights to IPF & lung cancer drug
March4 2011 Viral Infection and IPF
http://www.postandcourier.com/article/20110304/ARCHIVES/303049965
March 3 2011 InterMune Receives European Union Approval for Esbriet® (pirfenidone)
February 10 2011 New Pharmacological Strategies for the Treatment of Pulmonary Fibrosis
http://www.medscape.com/viewarticle/736828
January 25 2011 Advances in Proteomic Techniques for Biomarker Discovery in COPD
http://www.medscape.com/viewarticle/734885
IPF Today
Vienna, VA
United States
info